Direct repression of MYB by ZEB1 suppresses proliferation and epithelial gene expression during epithelial-to-mesenchymal transition of breast cancer cells
Authors:
- Honor J HugoHHHonor J Hugo
- Lloyd PereiraLPLloyd Pereira
- Randy SuryadinataRSRandy Suryadinata
- Yvette DrabschYDYvette Drabsch
- Thomas J GondaTGThomas J Gonda
- N P A Devika GunasingheNGN P A Devika Gunasinghe
- Cletus PintoCPCletus Pinto
- Eliza Tl SooESEliza Tl Soo
- Bryce Jw van DenderenBDBryce Jw van Denderen
- Prue HillPHPrue Hill
- Robert G RamsayRRRobert G Ramsay
- Boris SarcevicBSBoris Sarcevic
Open Access
- 27 November 2013
- journal article
- research article
- Published by Springer Nature in Breast Cancer Research
- Vol. 15 (6) , R113
Abstract
Introduction: Epithelial-to-mesenchymal transition (EMT) promotes cell migration and is important in metastasis. Cellular proliferation is often downregulated during EMT, and the reverse transition (MET) in metastases appears to be required for restoration of proliferation in secondary tumors. We studied the interplay between EMT and proliferation control by MYB in breast cancer cells. Methods: MYB, ZEB1, and CDH1 expression levels were manipulated by lentiviral small-hairpin RNA (shRNA)-mediated knockdown/overexpression, and verified with Western blotting, immunocytochemistry, and qRT-PCR. Proliferation was assessed with bromodeoxyuridine pulse labeling and flow cytometry, and sulforhodamine B assays. EMT was induced with epidermal growth factor for 9 days or by exposure to hypoxia (1% oxygen) for up to 5 days, and assessed with qRT-PCR, cell morphology, and colony morphology. Protein expression in human breast cancers was assessed with immunohistochemistry. ZEB1-MYB promoter binding and repression were determined with Chromatin Immunoprecipitation Assay and a luciferase reporter assay, respectively. Student paired t tests, Mann–Whitney, and repeated measures two-way ANOVA tests determined statistical significance (P < 0.05). Results: Parental PMC42-ET cells displayed higher expression of ZEB1 and lower expression of MYB than did the PMC42-LA epithelial variant. Knockdown of ZEB1 in PMC42-ET and MDA-MB-231 cells caused increased expression of MYB and a transition to a more epithelial phenotype, which in PMC42-ET cells was coupled with increased proliferation. Indeed, we observed an inverse relation between MYB and ZEB1 expression in two in vitro EMT cell models, in matched human breast tumors and lymph node metastases, and in human breast cancer cell lines. Knockdown of MYB in PMC42-LA cells (MYBsh-LA) led to morphologic changes and protein expression consistent with an EMT. ZEB1 expression was raised in MYBsh-LA cells and significantly repressed in MYB-overexpressing MDA-MB-231 cells, which also showed reduced random migration and a shift from mesenchymal to epithelial colony morphology in two dimensional monolayer cultures. Finally, we detected binding of ZEB1 to MYB promoter in PMC42-ET cells, and ZEB1 overexpression repressed MYB promoter activity. Conclusions: This work identifies ZEB1 as a transcriptional repressor of MYB and suggests a reciprocal MYB-ZEB1 repressive relation, providing a mechanism through which proliferation and the epithelial phenotype may be coordinately modulated in breast cancer cells.Keywords
This publication has 80 references indexed in Scilit:
- Tumor Metastasis: Molecular Insights and Evolving ParadigmsCell, 2011
- Does tumour dormancy offer a therapeutic target?Nature Reviews Cancer, 2010
- A reciprocal repression between ZEB1 and members of the miR‐200 family promotes EMT and invasion in cancer cellsEMBO Reports, 2008
- The Epithelial-Mesenchymal Transition Generates Cells with Properties of Stem CellsCell, 2008
- Mechanism of and requirement for estrogen-regulated MYB expression in estrogen-receptor-positive breast cancer cellsProceedings of the National Academy of Sciences, 2007
- The transcription factor ZEB1 (δEF1) promotes tumour cell dedifferentiation by repressing master regulators of epithelial polarityOncogene, 2007
- Three-dimensional culture models of normal and malignant breast epithelial cellsNature Methods, 2007
- The transcription factor ZEB1 (δEF1) represses Plakophilin 3 during human cancer progressionFEBS Letters, 2007
- A collection of breast cancer cell lines for the study of functionally distinct cancer subtypesCancer Cell, 2006
- Mutations in the MYB intron I regulatory sequence increase transcription in colon cancersGenes, Chromosomes and Cancer, 2006